Earnings History Data for CymaBay Therapeutics Inc. (CBAY) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

CymaBay Therapeutics Inc.

CymaBay Therapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of proprietary new medicines for important human diseases. The Company's lead product candidate, arhalofenate, is being developed for the treatment of gout. CymaBay Therapeutics Inc. is based in Newark, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
11-08-2022 AH 4:05 PM ET
(Aug 11)
CBAY CymaBay Therapeutics Inc. 266.74 -0.31 -0.30 -0.34 CymaBay Therapeutics GAAP EPS of -$0.31 misses by $0.01
[8/11/2022 4:12 PM]
4.04 0.30 
(8.02%)
3.90 0.16 
(4.28%)
1.67 - 4.74 438,919 770,000 2,957
12-05-2022 AH 4:05 PM ET
(May 12)
CBAY CymaBay Therapeutics Inc. 158.35 -0.32 -0.31 -0.25 CymaBay Therapeutics GAAP EPS of -$0.32 misses by $0.01
[5/12/2022 4:17 PM]
1.80 0.03 
(1.40%)
2.00 0.22 
(12.36%)
1.67 - 5.06 444,362 820,000 1,559
17-03-2022 AH 4:05 PM ET
(Mar 17)
CBAY CymaBay Therapeutics Inc. 251.47 -0.34 -0.36 -0.23 CymaBay Therapeutics GAAP EPS of -$0.34 misses by $0.11
[3/17/2022 4:09 PM]
3.17 -0.01 
(-0.31%)
3.12 -0.06 
(-1.89%)
2.67 - 5.13 1,089,791 417,308 10,177
10-11-2021 AH 4:05 PM ET
(Nov 10)
CBAY CymaBay Therapeutics Inc. 302.90 -0.33 -0.29 -0.17 CymaBay Therapeutics EPS misses by $0.08
[11/10/2021 5:22 PM]
4.32 0.04 
(0.93%)
4.50 0.22 
(5.14%)
3.39 - 8.48 445,043 370,000 13,059
12-08-2021 AH 4:05 PM ET
(Aug 12)
CBAY CymaBay Therapeutics Inc. 263.56 -0.34 -0.27 -0.16 CymaBay Therapeutics EPS misses by $0.07
[8/12/2021 4:21 PM]
3.62 -0.34 
(-8.59%)
3.85 -0.11 
(-2.78%)
3.56 - 9.06 607,817 430,000 684
13-05-2021 AH 4:10 PM ET
(May 13)
CBAY CymaBay Therapeutics Inc. 295.79 -0.25 -0.24 -0.19 CymaBay Therapeutics EPS misses by $0.01
[5/13/2021 4:32 PM]
4.30 0.18 
(4.37%)
4.01 -0.10 
(-2.55%)
3.16 - 9.06 664,611 950,000 2,180
25-03-2021 AH 4:05 PM ET
(Mar 25)
CBAY CymaBay Therapeutics Inc. 329.28 -0.23 -0.20 -0.35 CymaBay Therapeutics EPS misses by $0.03
[3/25/2021 4:13 PM]
4.49 -0.10 
(-2.29%)
4.65 0.06 
(1.31%)
1.38 - 9.06 841,157 840,000 5,491
05-11-2020 AH 4:00 PM ET
(Nov 5)
CBAY CymaBay Therapeutics Inc. 573.83 -0.17 -0.17 -0.38 CymaBay Therapeutics EPS in-line
[11/5/2020 4:27 PM]
7.83 -0.67 
(-7.88%)
8.50 0.0 
(0.00%)
1.21 - 9.06 1,180,174 926,128 61,412
10-08-2020 AH 4:00 PM ET
(Aug 10)
CBAY CymaBay Therapeutics Inc. 394.70 -0.16 -0.23 -0.35 CymaBay Therapeutics EPS beats by $0.08
[8/10/2020 4:23 PM]
6.03 -0.87 
(-12.61%)
6.40 -0.50 
(-7.25%)
1.21 - 7.09 2,666,678 9,793,502 95,048